Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Sanne Steyaert"'
Autor:
Nika Schuermans, Dimitri Hemelsoet, Wim Terryn, Sanne Steyaert, Rudy Van Coster, Paul J. Coucke, Wouter Steyaert, Bert Callewaert, Elke Bogaert, Patrick Verloo, Arnaud V. Vanlander, Elke Debackere, Jody Ghijsels, Pontus LeBlanc, Hannah Verdin, Leslie Naesens, Filomeen Haerynck, Steven Callens, Bart Dermaut, Bruce Poppe, for UD-PrOZA
Publikováno v:
Orphanet Journal of Rare Diseases, Vol 17, Iss 1, Pp 1-13 (2022)
Abstract Background In order to facilitate the diagnostic process for adult patients suffering from a rare disease, the Undiagnosed Disease Program (UD-PrOZA) was founded in 2015 at the Ghent University Hospital in Belgium. In this study we report th
Externí odkaz:
https://doaj.org/article/132a277748754b7f9f15a3480f1078a1
Publikováno v:
PLoS ONE, Vol 14, Iss 2, p e0207045 (2019)
BACKGROUND:Clinical trials are most informative for evidence-based decision-making when they consistently measure and report outcomes of relevance to stakeholders, especially patients, clinicians, and policy makers. However, sometimes terminology use
Externí odkaz:
https://doaj.org/article/681f50adc7d74229b7b56bcd2b40e9c6
Publikováno v:
Acta Clinica Belgica. 73:229-232
Recurrence of membranous glomerulonephritis after transplant is common and is an important cause of loss of renal graft. This case supports the effect of immunoglobulins in the treatment of this disease after transplantation. It is the first report i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::18df0ef7515e1fa7e3858655f3f2776b
https://doi.org/10.1080/17843286.2017.1361622
https://doi.org/10.1080/17843286.2017.1361622
Publikováno v:
Infection control and hospital epidemiology. 40(4)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ffaf44084f91c226afaf289dbdf21260
https://pubmed.ncbi.nlm.nih.gov/30767820
https://pubmed.ncbi.nlm.nih.gov/30767820
BackgroundClinical trials are most informative for evidence-based decision-making when they consistently measure and report outcomes of relevance to stakeholders, especially patients, clinicians, and policy makers. However, sometimes terminology used
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::03b74a0ba64794039058d651a4fcc9be
https://doi.org/10.1101/453191
https://doi.org/10.1101/453191
Publikováno v:
PLoS ONE
PLoS ONE, Vol 14, Iss 2, p e0207045 (2019)
PLOS ONE
PLoS ONE, Vol 14, Iss 2, p e0207045 (2019)
PLOS ONE
Background : Clinical trials are most informative for evidence-based decision-making when they consistently measure and report outcomes of relevance to stakeholders, especially patients, clinicians, and policy makers. However, sometimes terminology u
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dfcc7a14f8b84a98d8d1cea237fe2ab6
https://pubmed.ncbi.nlm.nih.gov/30721242
https://pubmed.ncbi.nlm.nih.gov/30721242